| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| A_VSI_CL_Fr_2.bak | 2026-07-31 20:08 | 213K | ||
| A_VSI_CL_Fr.doc.bak.bak | 2026-07-31 20:08 | 486K | ||
| A_VSI_CL_Fr.doc.bak | 2026-07-31 20:08 | 108K | ||
| A_VSI_CL_Fr.bak | 2026-07-31 20:08 | 83K | ||
| A_Statistiques_CL2.bak | 2026-07-31 20:08 | 64K | ||
| A_SITE_CL.docx | 2026-07-31 20:08 | 79K | ||
| A_Rapport_Orga_DM.docx | 2026-07-31 20:08 | 84K | ||
| A_RapportEC__Report_En.doc.bak | 2026-07-31 20:08 | 173K | ||
| A_Pharmacovigilance_Questionnaire.doc.bak | 2026-07-31 20:08 | 23K | ||
| A_Pharmacovigilance_CL_En.doc.bak | 2026-07-31 20:08 | 276K | ||
| A_Pharmacovigilance_Agenda_F.doc.bak | 2026-07-31 20:08 | 109K | ||
| a_pd_rpa.docx | 2026-07-31 20:08 | 76K | ||
| a_pd_prf.docx | 2026-07-31 20:08 | 80K | ||
| a_pd_pra.docx | 2026-07-31 20:08 | 79K | ||
| a_pd_pha.docx | 2026-07-31 20:08 | 78K | ||
| a_pd_moa.docx | 2026-07-31 20:08 | 80K | ||
| a_pd_ipa.docx | 2026-07-31 20:08 | 81K | ||
| a_pd_dof.docx | 2026-07-31 20:08 | 103K | ||
| a_pd_doa.docx | 2026-07-31 20:08 | 80K | ||
| a_pd_dmf.docx | 2026-07-31 20:08 | 81K | ||
| a_pd_dma.docx | 2026-07-31 20:08 | 82K | ||
| a_j_sys.docx | 2026-07-31 20:08 | 27K | ||
| a_j_inv.docx | 2026-07-31 20:08 | 28K | ||
| a_j_ins.docx | 2026-07-31 20:08 | 29K | ||
| a_j_ec.docx | 2026-07-31 20:08 | 27K | ||
| a_j_cro.docx | 2026-07-31 20:08 | 28K | ||
| A_Epidemio_TMF_Rapport_Fr.doc.bak | 2026-07-31 20:08 | 86K | ||
| A_Epidemio_TMF_Rapport_Fr.bak | 2026-07-31 20:08 | 62K | ||
| A_EC_TMF_Report_En.bak | 2026-07-31 20:08 | 188K | ||
| A_EC_TMF_Rapport_Fr.bak | 2026-07-31 20:08 | 113K | ||
| A_EC_Site_Report_En.bak | 2026-07-31 20:08 | 130K | ||
| A_EC_Fr.doc.bak | 2026-07-31 20:08 | 66K | ||
| A_EC_En.doc.bak | 2026-07-31 20:08 | 134K | ||
| A_cro__angl_cl.docx | 2026-07-31 20:08 | 99K | ||